Ad is loading...
JWSOX vs VEXRX
JWSOX vs VEXRX Comparison
Open Charts JWSOX vs VEXRX
JHancock New Opportunities R6
Price$22.93
Change+$0.38 (+1.69%)
VolumeN/A
Net Assets245.12M
JWSOX vs VEXRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
JWSOX vs. VEXRX commentary
Apr 24, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JWSOX is a Buy and VEXRX is a Buy.
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 19.8B vs. JWSOX (245M). VEXRX pays higher dividends than JWSOX: VEXRX (0.56) vs JWSOX (0.00). JWSOX was incepted earlier than VEXRX: JWSOX (10 years) vs VEXRX (23 years). JWSOX (0.86) is less costly to investors than VEXRX (0.34). VEXRX is a more actively managed with annual turnover of: 35.00 vs. JWSOX (15.00). VEXRX has a lower initial minimum investment than JWSOX: VEXRX (50000) vs JWSOX (1000000). JWSOX annual gain was more profitable for investors over the last year : -8.33 vs. VEXRX (-12.82). JWSOX return over 5 years is better than : 16.96 vs. VEXRX (15.80).
| JWSOX | VEXRX | JWSOX / VEXRX | |
| Total Expense Ratio | 0.85 | 0.34 | 250% |
| Annual Report Gross Expense Ratio | 0.86 | 0.34 | 253% |
| Fund Existence | 10 years | 23 years | - |
| Gain YTD | -14.906 | -14.722 | 101% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 50000 | 2,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 245M | 19.8B | 1% |
| Annual Yield % from dividends | 0.00 | 0.56 | - |
| Returns for 1 year | -8.33 | -12.82 | 65% |
| Returns for 3 years | -14.65 | -9.40 | 156% |
| Returns for 5 years | 16.96 | 15.80 | 107% |
| Returns for 10 years | N/A | -1.76 | - |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XBI | 79.10 | 1.46 | +1.88% |
| SPDR® S&P Biotech ETF | |||
| CHI | 9.78 | 0.17 | +1.77% |
| Calamos Convertible Opportunities and Income Fund | |||
| SBIO | 28.02 | 0.45 | +1.63% |
| ALPS Medical Breakthroughs ETF | |||
| BCDF | 28.54 | 0.12 | +0.44% |
| Horizon Kinetics Blockchain Dev ETF | |||
| FEP | 41.67 | -0.06 | -0.14% |
| First Trust Europe AlphaDEX® ETF | |||